BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:18 pm Sale |
2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BIOTECHNOLOGY VALUE FUND L P | 57,438 1.500% |
-106,766 (-65.02%) |
Filing |